Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05080621
Title Ripretinib in Combination With Binimetinib in Patients With Gastrointestinal Stromal Tumor (GIST)
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Deciphera Pharmaceuticals LLC

gastrointestinal stromal tumor


Binimetinib + Ripretinib

Age Groups: senior | adult
Covered Countries

No variant requirements are available.